Oncoproteomics: State-of-the-art

Technology in Cancer Research and Treatment

Volumn 1, Issue 4, 2002, Pages 219-220

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA;

BIOCHEMISTRY; CARCINOGENESIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG DETERMINATION; ONCOPROTEOMICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; REVIEW; TECHNOLOGY;

EID: 0037654887     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100401     Document Type: Review

References (10)

1. Choi, W. et al. Understanding cancer through proteomics. TCRT 1, 221-230 (2002).
2. Wang, H. and Hanash, M. S. Contributions of proteome profiling to the molecular analysis of cancer. TCRT 1, 237-246 (2002).
3. Jain, K. K. Role of proteomics in diagnosis of cancer. TCRT 1, 281-286 (2002).
4. Le Naour, F. et al. Identification of tumor-associated antigens using proteomics. TCRT 1, 257-262 (2002).
5. Yip, T. T. and Lomas, L. SELDI ProteinChip® Array in onco- proteomic research. TCRT 1, 273-280 (2002).
6. El Yazidi-Belkoura, I. et al. Proteomics of breast cancer: outcomes and prospects. TCRT 1, 287-296 (2002).
7. Steinert, R. et al. The Role of proteomics in the diagnosis and outcome prediction in colorectal cancer. TCRT 1, 297-304 (2002).
8. Krieg, R. C. et al. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. TCRT 1, 263-272 (2002).
9. Jain, K. K. Proteomics-based anticancer drug discovery and development. TCRT 1, 231-236 (2002).
10. Kovarova, H. et al. Application of proteomics in the search for novel proteins associated with the anti-cancer effect. TCRT 1, 247-256 (2002).